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CC BY-NC-ND license (http://creativeAbstract Backgrounds: Diabetes mellitus, especially type 2 diabetes, with its fast-rising
prevalence, has become a global epidemic. Mulberry (Morus alba L.) leaf has been known to
have hypoglycemic effects since ancient times. In Asia mulberry leaf is used as tea to comple-
ment the treatment of diabetes mellitus. The methods by which mulberry leaf affects the body
and its mechanism when combined with chemical agents have been studied extensively.
Conclusions: We summarize the possible mechanisms of the anti-diabetic effects of mulberry
leaf based on extraction procedures, in vitro and in vivo experiments, and clinical trials. We
also discuss the hypothesis that crosstalk and “critical nodes” may be useful for a deeper mo-
lecular understanding of the treatment and prevention of diabetes with mulberry leaf.
ª 2016 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Diabetes mellitus is a disease that affects the body’s
regulation of blood glucose, the main symptoms of which
include thirst, frequent urination, hunger, and weight loss.
Diabetes, especially type 2 diabetes metillus (T2DM), is
increasingly prevalent worldwide according to the WHO,om (B. Zhao).
Beijing University of Chinese
16.04.001
f Chinese Medicine. Production a
commons.org/licenses/by-nc-ndcalling for a monitoring of diabetes rates and researches
into cost-effective treatments to slow its rise.
As for the medicinal interventions, certain traditional
plants have been proved to retard the development of
diabetic mice induced by streptozotocin (STZ).1 Traditional
Chinese herbs have been shown to have beneficial effects
over Western pharmaceutical medications in treating dia-
betes, including duration effect, moderate hypoglycemic
effects, and fewer side effects.2
In China, mulberry (Morus alba L.) leaf has been used to
treat various illnesses since ancient times. Its use was first
recorded in Divine Husbandman’s Classic of Materia Medica
(Shennong Bencao Jing; 200e220 CE), which is the earliest
materia medica in China. The herb was described as beingnd hosting by Elsevier B.V. This is an open access article under the
/4.0/).
4 S. Tian et al.able to eliminate cold and heat in the body, promote
perspiration, and have detoxifying properties.3 With the
wider use of mulberry leaf, more properties and effects
were recorded in Comprehensive Outline of the Materia
Medica (Bencao Gangmu; 1590), an extensive summary of
Chinese herbal pharmacology. The author, Li Shizhen,
indicated that brewed mulberry tea can treat wasting and
thirsting (xiao ke) syndrome. It is now recognized that
diabetes falls under this syndrome.
Pharmacological experiments have shown that the
active compounds in mulberry leaf with hypoglycemic ef-
fects including alkaloids, flavonoids, polysaccharides,
amino acids, simple phenylpropanoids, and phenols.4 In this
brief review, we present the mechanisms of the anti-
diabetic effects of mulberry leaf from perspectives of ex-
tracts, their compounds, molecular mechanisms, and clin-
ical trials. We hope that this manuscript provides a
summary for future research on mulberry leaf as an herbal
supplement for T2DM.Extraction conditions resulting in the best anti-
diabetic effects in vitro and in vivo
In ancient China, dried mulberry leaf was brewed in hot
water to make a tea for treating diabetes. Modern extrac-
tion methods are now able to maximize treatment hypo-
glycemic effects with increased glucose uptake attributed
to various factors during extraction, such as brewing time,
concentration of organic solution, and extraction solution
temperature.Water extracts
Chen et al5 compared two extracts from mulberry leaf on
STZ-induced diabetic mice, and found that hot water ex-
tracts exhibited more potent hypoglycemic effects than
ethanol or n-butanol fractions. Attila et al6 investigated the
dichloromethane-soluble fraction from the hot water
extract of mulberry leaf had the potentiality to exert anti-
diabetic activity on the 3T3-L1 adipocytes. Powder of dried
mulberry leaf was given to diabetic rats by gavage, showing
no traces of lenticular opacity in diabetic-mulberry group
and no significant differences of blood glucose in normal
group.7 When a mixture of mulberry leaf and mulberry tea
was steeped in hot water (98C) for 3e5 min, a stronger
inhibitory effect on a-glucosidase was observed in a Caco-
2 cell culture experiment, compared with other extraction
conditions.8Ethanolic and other extracts
Aside from the water extract, the ethanol extract of mul-
berry leaf is effective at treating diabetes in STZ-induced
rats,9,10 So is the acetone extract, however, it is not so well
as the ethanolic.11,12 From these studies, it is clear that the
mulberry extraction method plays a crucial role in pre-
venting diabetes, and each extract has different hypogly-
cemic effects.Mechanisms of the anti-diabetes effects of
mulberry leaf in vivo
After confirming that crude extracts from mulberry leaf
have hypoglycemic effects, additional extracts are purified
for mechanistic studies. In these studies, various extracts
from mulberry leaf are separated with reagents under
different conditions, and active constituents are detected
and enriched. Here we summarize these mechanistic
studies with respect to their extracts.
Inhibition of a-glucosidase
Alkaloids
Total alkaloids frommulberry leaf have hypoglycemic effects
in streptozotocin- (STZ-) induced diabetic mice.13 Some al-
kaloids in mulberry leaf are potent inhibitors of mammalian
digestive glycosidases.14 These mulberry alkaloids, espe-
cially 1-deoxynojirimycin (DNJ), decrease a-glucosidase ac-
tivity by competitive inhibition through binding to the
enzyme active site to mimic natural substrates.15
DNJ-enriched mulberry extract may be useful in con-
trolling postprandial hyperglycemia in pre-diabetic or mild
diabetic individuals.16 Oral administration of 0.24% DNJ and
its derivatives was found to inhibit absorption of sucrose
and polysaccharides in human and rat intestinal tissue
samples.17 Other investigations on the pharmacokinetics
and bioavailability of DNJ showed that oral mulberry DNJ
administered to rats is absorbed intact from the gastroin-
testinal tract, diffuses into the liver, and is then excreted
with a short half-life.18,19 Thus, studies such as the afore-
mentioned on the metabolism of DNJ help lay the founda-
tion for developing mulberry leaf as a dietary supplement
for diabetes. As such, extracting the highest DNJ content as
possible from mulberry is a high priority. In studies that
investigated extraction of DNJ, when temperature was
sustained at 98C for 400 s, 95% of DNJ in dry mulberry tea
was extracted20 and water extraction versus extraction
using different concentrations of ethanol produced varying
contents of DNJ.21 Other studies are exploring ways to in-
crease production of DNJ during fermentation of mulberry
leaf, such as inoculating the fermentation broth with the
fungus ganoderma (Ganoderma lucidum).22
Flavonoids
Flavonoids from mulberry leaf also have in vitro inhibitory
effects on a-glucosidase activity and can suppress blood
glucose level after oral administration of starch and sucrose
in Kunming mice.23 Two flavonoids (isoquercitrin and
astragalin) were shown to inhibit a-glucosidase as for the
laboratory experiment.24 Furthermore, chlorogenic acid (a
phenylpropanoid) and rutin were found to play an impor-
tant role in preventing diabetes, but not isoquercitrin.25
Polysaccharides
Polysaccharides from mulberry leaf have been shown to
decrease blood glucose level, improve glucose tolerance,
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lating glucose metabolism in diabetic mice and promoting
insulin secretion in normal rats.26 Polysaccharides from
mulberry leaf have also been found to inhibit a-glucosi-
dase activity.27 The highly-purified polysaccharides a-
arabinose, a-xylose, a-glucose, a-rhamnose, and a-
mannose that were extracted from mulberry leaf were
able to induce regeneration of pancreatic b-cells, which
were then able to effectively secreted insulin and reduce
liver fat accumulation in diabetic rats.28 Glycosides and
their aglycons that were isolated from a water extract of
mulberry leaf were found to have potential type 2 anti-
diabetic activity.29
While the inhibition of a-glucosidase plays a crucial role
in the anti-diabetes effect of mulberry leaf, an individual
compound cannot elucidate metabolic mechanisms, thus
molecular mechanisms need investigating.Gluconeogenesis and glycolysis
The rate of hepatic glycogenolysis decreases after an
overnight fast, such that an increase in blood glucose in
type 2 diabetics is caused by gluconeogenesis.30 Under
similar conditions in diabetic rats, mulberry leaf was
shown to decrease the activities of key hepatic gluco-
neogenic enzymes, glucose-6-phosphatase (G-6-ase),
fructose 1,6-diphosphatase (FDPase), and phosphoenol-
pyruvate carboxy kinase (PEPCK).31 Using real time-PCR
analysis, DNJ plus polysaccharide (HDP) was found to
up/down-regulate glucokinase (GCK), PEPCK, and G-6-
ase.18
All carbohydrates undergo glycolysis, but this process is
more active in healthy persons than in diabetics.32 The
glycolytic enzymes hexokinase, operating partial inhibition,
phosphofructokinase-1, the important control point, and
pyruvate kinase are involved in gluconeogenesis.33 Howev-
er, mulberry leaf extract did not significantly alter the ac-
tivities of hexokinase and phosphofructokinase-1, while
glucokinase did in STZ-induced diabetic rats.34
Results from studies such as those, it appears mulberry
leaf likely suppresses gluconeogenesis and promotes
glycolysis. Although some studies focused on gluconeogen-
esis and glycogenolysis, their results are insufficient to
explain why mulberry leaf could have an anti-diabetic ef-
fect, and how it affects each step in gluconeogenesis and
glycogenolysis.AMPK signaling
AMP-activated protein kinase (AMPK) is a regulator of
intracellular and systemic energy metabolism. Research
has found that AMPK can be targeted in the treatment of
diabetes and metabolic syndrome.35 One study found that
a hot water extract of mulberry leaf could activate
skeletal muscle AMPK signaling, as shown by increased
uptake of 3-O-methyl-D-glucose transport and was also
involved in phosphorylation of Akt substrate of 160 kDa
(AS160) and acetyl-CoA carboxylase, without any energy
changes.36Anti-apoptosis of b-cells
Increased b-cell apoptosis leads to b-cell loss and results in
onset of type 2 diabetes.37 Apoptosis is a fundamental
mechanism for homeostasis and a form of programed cell
death, with 2 large protein families involved in the process:
the caspase family and the B-cell lymphoma 2 (Bcl-2) pro-
teins. These two protein families are linked with the
development of insulin resistance,38 with the increased
ratio of Bax/Bcl-2 and caspase-3 showing an association
with diabetes.39 Polysaccharides from mulberry leaf have
been shown to elevate the Bcl-2/Bax ratio to protect
pancreatic islet cells from apoptosis.40 However, the Bcl-2
family is divided into 3 subgroups,41 thus further study is
needed to determine which proteins are altered when
mulberry leaf is administered.PI3K/Akt signaling
The glucose transporter GLUT4 is an insulin-sensitive
transporter that can facilitate a decreased plasma glucose
level. GLUT4 is translocated to the plasma membrane via
the lipid kinase phosphatidylinositol 3-kinase (PI3K)
signaling pathway.42 Additionally, pancreatic duodenal
homeobox-1 (PDX-1) is a regulator of beta cell identity and
function in pancreatic islets. Glucose-simulated PDX-1 DNA-
binding activity is inhibited by inhibitors of PI3K, such as
wortmannin,43 which was used to validate the hypoglyce-
mic mechanism of mulberry leaf. Therefore, mulberry leaf
extract might mediate hyperglycemia by increasing glucose
uptake via the PI3K pathway and translocation of GLUT4 to
the plasma membrane, with gallic acid the specific com-
pound that mediates this effect.44 In addition, poly-
saccharides from mulberry leaf have been shown to up-
regulate PDX-1, insulin-1, and insulin-2 expressions in the
pancreas.18
The serine/threonine protein kinase Akt is a major
target downstream of PI3K, and PI3K and Akt appear to
activate islet b-cells. Thus, islet-cell damage caused by
oxidative stress may be attenuated via the PI3KeAkt
pathway.45 PTP1B is a phospho-tyrosine protein phospha-
tase that negatively modulates insulin sensitivity and is a
substrate for Akt.46 Polysaccharides from mulberry leaf
have been shown to inhibit PTP1B, activate the PI3KeAkt
pathway, and reduce oxidative stress resulting in anti-
diabetic effects.47
The early studies cited in the text have illustrated that
polysaccharides from mulberry leaf could activate PI3K/Akt
pathway and elevate Bcl-2/Bax ratio to protect pancreatic
islet cell from apoptosis. There are some important facts to
support our hypothesis: 1) Akt has direct effects on regu-
lating apoptosis, and there also exists connections between
PI3-kinase pathways and control of apoptosis48; 2) PI3K/Akt
pathway inhibits Bax translocation and could promote sur-
vival49; Akt possibly promote cell survival through inacti-
vation of Bad with phosphorylation and up-regulation of
Bcl-2.48,50,51
Thus we hypothesize that polysaccharides from mul-
berry leaf initiate Akt in PI3K/Akt pathway, which could
inhibit Bax translocation and phosphorylate and up-
6 S. Tian et al.regulate of Bcl-2, but as for which isoform of Akt exerts
such function needs the research.
As for the current researches, crosstalk with signaling
cascades and the network among the pathways has been
introduced and the “critical nodes” are shown to define the
junctions.52 The study has demonstrated the significant
crosstalk between the AMPK and PI3K/Akt in embryonic
cells,53 and the mammalian target of rapamycin complex 1
(mTORC2) has been identified as a site of signaling crosstalk
and it has used to study the molecular mechanism of
metformin.54
In the domain of physiopathology, AMPK enhances in-
sulin sensitivity involved in direct regulation of PI3K and
stimulates PI3K/Akt.55 As for the mulberry leaf, since
mulberry hot water extract could increase the phosphor-
ylation of AS160, however, without significant change in
Akt in skeletal muscle cell. Two possible interpretations
might elucidate this result: 1) The active compounds in
the extracts under different extraction condition could
make a difference; 2) Researches have showed that the
primary role Akt2 is highlighted in adipocytes on insulin
responsiveness and the isoforms of Akt have their own
structures and functions,52 may be deeper researches will
fulfill the finding that extracts from mulberry leaf could
have relations with crosstalk between AMPK and PI3K/Akt
pathways.Peroxisome proliferator-activated receptors
(PPARs)
The peroxisome proliferator-activated receptors (PPARs)
are important in insulin resistance, hyperlipidemia, and
diabetes.56 Water extract of mulberry leaf was found to
increase insulin sensitivity and attenuate hyperglycemia
through up-regulation of PPAR expression in diabetic
mice.57 3T3-1L can be used to study the development of
insulin resistance because of a reduced GLUT4 pool.58 It is
found that PPARg agonists have been found to strengthen
basal and insulin-stimulated glucose uptake in 3T3-L1
adipocytes.59 Mulberry leaf extract was shown to signifi-
cantly increase secretion of adiponectin in 3T3-L1 and
enhanced the expression of PPARg. Therefore, the anti-
diabetic mechanism of mulberry leaf may be attribut-
able to stimulation of adipogenic activity and adiponectin
secretion.60Mechanisms under investigation
Mulberry leaf continues to be investigated for its hypo-
glycemic mechanism. For example, the anti-diabetic
function of mulberry leaf is correlated with anti-
inflammatory reactions.61 Furthermore, Attenuation of
insulin resistance may contribute to regulation of the
genes in the c-Jun amino-terminal kinase (JNK) signaling
pathway.62 As inflammation is closely associated with
metabolic disorder and the JNK pathway is an inflamma-
tory pathway, in the light of it, one hypothesis can be
assumed that mulberry leaf might be anti-diabetes
through anti-inflammation.Clinical trials
It is important to conduct studies with diabetic patients and
healthy volunteers to understand how natural products
such as mulberry leaf work in the body. This is because
botanical products have many pharmacologically-active
constituents that can interact with each other as well as
with pharmaceutical drugs.63
Thirty-day treatment with mulberry powder was found
to significantly lower fasting blood glucose compared with
glibenclamide.64 Other studies have found that treatment
with mulberry tea can cause malabsorption of
carbohydrates.65,66
Several clinical trials have focused on the enriched
compounds of mulberry leaf. To evaluate the effect of
mulberry leaf extract with enriched DNJ on postprandial
hyperglycemia, parameters, such as serum 1,5-
anhydrogluctol concentration, can be used as a sign for
positive improvement of impaired glucose metabolism.67 In
contrast, significant differences in postprandial hypergly-
cemia can be analyzed alone.68 Results of a clinical trial
that combined dietary control, exercise, and the total al-
kali fraction from mulberry leaf showed a reduction of
blood glucose, regulation of lipids, and fewer side effects
compared with acarbose treatment.69 Mulberry tea has also
been shown to suppress postprandial hyperglycemia after
90 min of its consumption.70
While the aforementioned studies have shown that
mulberry leaf decreases blood glucose, regulates glucose
and lipid metabolism, has few adverse effects, and may
exert a wider treatment range than pharmaceuticals. There
is a lack of research focusing on the safety of mulberry leaf.
Therefore, investigations are needed on the absorption,
distribution, metabolism, and excretion of compounds in
mulberry.14Discussion and conclusion
The anti-diabetes mechanism of mulberry leaf remains
incompletely understood at the molecular level. However,
active compounds in mulberry leaf likely affect crosstalk
among the signal transduction pathways and networks. A
single pathway cannot explain the hypoglycemic effect of
mulberry leaf. Therefore, the crosstalk between AMPK and
PI3K/Akt may be worth exploring for the anti-diabetic ef-
fects of mulberry leaf compounds.
More extensive clinical research should also be con-
ducted on mulberry leaf’s potentiality as a hypoglycemic
agent. For example, well-designed randomized controlled
trials, the gold standard for evaluating whether an inter-
vention is effective, should be performed to validate and
confirm findings of molecular studies.Acknowledgments
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